Cindy  Reiss-Clark net worth and biography

Cindy Reiss-Clark Biography and Net Worth

Cindy Reiss-Clark serves as Senior Vice President of Global Market Units and Commercial Solutions of the Company. Ms. Cindy serves as Senior Vice President, Global Market Units and Commercial Solution and is responsible for leading the marketing-led strategies for West’s four market units—Biologics, Pharma, Generics and Contract Manufacturing. In her role, she oversees West’s overall sales strategy including the Company’s scientific affairs and technical customer service teams, and also manages West’s commercial strategic partnerships and business development efforts. Cindy most recently served as General Manager, Biologics Market Unit. Prior to joining West, Cindy served as Senior Vice President leading the Marketing and Sales organizations for the Pharma and Biotech business unit at Lonza which provides customized Contract Development and Manufacturing services to Pharmaceutical and Biotech organizations. Cindy holds a Bachelor of Arts in Biological Chemistry from the University of Kansas, where she is a member of the Biological Advisory Board.

What is Cindy Reiss-Clark's net worth?

The estimated net worth of Cindy Reiss-Clark is at least $1.48 million as of August 22nd, 2023. Ms. Reiss-Clark owns 4,320 shares of West Pharmaceutical Services stock worth more than $1,478,174 as of December 6th. This net worth approximation does not reflect any other assets that Ms. Reiss-Clark may own. Additionally, Ms. Reiss-Clark receives a salary of $775,490.00 as Insider at West Pharmaceutical Services. Learn More about Cindy Reiss-Clark's net worth.

How old is Cindy Reiss-Clark?

Ms. Reiss-Clark is currently 49 years old. There are 8 older executives and no younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services is Mr. Christopher G. Ryan, Senior Vice President of Containment & Glass Systems, who is 62 years old. Learn More on Cindy Reiss-Clark's age.

What is Cindy Reiss-Clark's salary?

As the Insider of West Pharmaceutical Services, Inc., Ms. Reiss-Clark earns $775,490.00 per year. There are 4 executives that earn more than Ms. Reiss-Clark. The highest earning executive at West Pharmaceutical Services is Mr. Eric M. Green, Chair, President & CEO, who commands a salary of $1,920,000.00 per year. Learn More on Cindy Reiss-Clark's salary.

How do I contact Cindy Reiss-Clark?

The corporate mailing address for Ms. Reiss-Clark and other West Pharmaceutical Services executives is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. West Pharmaceutical Services can also be reached via phone at (610) 594-2900 and via email at [email protected]. Learn More on Cindy Reiss-Clark's contact information.

Has Cindy Reiss-Clark been buying or selling shares of West Pharmaceutical Services?

Cindy Reiss-Clark has not been actively trading shares of West Pharmaceutical Services during the last ninety days. Most recently, Cindy Reiss-Clark sold 3,477 shares of the business's stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $393.34, for a transaction totalling $1,367,643.18. Following the completion of the sale, the insider now directly owns 4,320 shares of the company's stock, valued at $1,699,228.80. Learn More on Cindy Reiss-Clark's trading history.

Who are West Pharmaceutical Services' active insiders?

West Pharmaceutical Services' insider roster includes Silji Abraham (Insider), Bernard Birkett (SVP), Annette Favorite (VP), Eric Green (CEO), Thomas Hofmann (Director), Quintin Lai (VP), George Miller (VP), Cindy Reiss-Clark (Insider), and Patrick Zenner (Director). Learn More on West Pharmaceutical Services' active insiders.

Are insiders buying or selling shares of West Pharmaceutical Services?

In the last twelve months, insiders at the medical instruments supplier sold shares 15 times. They sold a total of 173,699 shares worth more than $62,572,781.42. The most recent insider tranaction occured on December, 1st when CAO Chad Winters sold 1,013 shares worth more than $353,537.00. Insiders at West Pharmaceutical Services own 1.1% of the company. Learn More about insider trades at West Pharmaceutical Services.

Information on this page was last updated on 12/1/2023.

Cindy Reiss-Clark Insider Trading History at West Pharmaceutical Services

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2023Sell3,477$393.34$1,367,643.184,320View SEC Filing Icon  
See Full Table

Cindy Reiss-Clark Buying and Selling Activity at West Pharmaceutical Services

This chart shows Cindy Reiss-Clark's buying and selling at West Pharmaceutical Services by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

West Pharmaceutical Services Company Overview

West Pharmaceutical Services logo
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Read More

Today's Range

Now: $342.17
Low: $341.78
High: $347.10

50 Day Range

MA: $355.80
Low: $318.29
High: $392.21

2 Week Range

Now: $342.17
Low: $224.15
High: $415.73


82,027 shs

Average Volume

438,667 shs

Market Capitalization

$25.32 billion

P/E Ratio


Dividend Yield